01/27/2014

Notice for establishment of distributors

01/17/2014

Notice for Large Volume Exercise and Completion of the 37th Round of Stock Option

01/14/2014

Notice for F647 commercial name

01/06/2014

GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China

01/06/2014

（Amendment）GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China

01/06/2014

Notice for Exercise of the 37th Round of Stock Options in December, 2013

01/06/2014

Notice for Large Volume Exercise of the 37th Round of Stock Option

12/06/2013

GNI Group Ltd. Announces a Licensing Agreement for its IPF therapy drug Etuary with AFT Pharmaceuticals for the ASEAN, Australasian and CIS Markets

12/02/2013

Notice for Exercise of the 37th Round of Stock Options in November, 2013

11/22/2013

Notice for Large Volume Exercise of the 37th Round of Stock Options

11/21/2013

Patent Allowance for F200 in China

11/21/2013

Notice of Development of Topical Medication Product

11/12/2013

Notice for Large Volume Exercise of the 37th Round of Stock Options

11/01/2013

Notice for Exercise of the 36th Round of Stock Options in October, 2013 and its Acquisition and Cancellation

11/01/2013

Notice for Exercise of the 37th Round of Stock Options in October, 2013 and its Acquisition and Cancellation